[MYGN] QoQ Quarter Result on 31-Dec-2020 [#Q4]

Stock
[MYGN] Myriad Genetics, Inc.
Announcement Date
31-Dec-2020
Financial Year
2020
Quarter
31-Dec-2020 [#Q4]
Profit Trend
QoQ- -190.79%
YoY- -432.53%
Quarter Report
MYGN's Result
MYGN's Financial Summary
View:
Show?
Quarter Result
30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 CAGR
Revenue 167,300 189,400 173,100 154,600 145,200 93,200 164,000 1.33%
PBT 39,800 -3,800 -49,600 -55,700 -43,700 -58,500 -131,100 -
Tax 15,200 900 -10,100 -11,500 -28,500 -3,000 -15,900 -
NP 24,600 -4,700 -39,500 -44,200 -15,200 -55,400 -115,200 -
Tax Rate -38.19% - - - - - - -
Total Cost 142,700 194,100 212,600 198,800 160,400 148,600 279,200 -36.04%
Ratio Analysis
30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 CAGR
NP Margin 14.70 -2.48 -22.82 -28.59 -10.47 -59.44 -70.24 -
Per Share
30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 CAGR
EPS 0.31 -0.06 -0.52 -0.59 -0.20 -0.74 -1.55 -
EPS Diluted 0.30 -0.06 -0.52 -0.59 -0.20 -0.74 -1.55 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.